ACSDX | VIVIX | ACSDX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 26 years | - |
Gain YTD | 14.186 | 16.286 | 87% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12B | 183B | 7% |
Annual Yield % from dividends | 1.71 | 2.37 | 72% |
Returns for 1 year | 14.88 | 24.01 | 62% |
Returns for 3 years | 12.26 | 28.27 | 43% |
Returns for 5 years | 34.84 | 55.47 | 63% |
Returns for 10 years | 40.29 | 114.02 | 35% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
OACP | 23.56 | 0.01 | +0.04% |
OneAscent Core Plus Bond ETF | |||
GERM | 19.16 | N/A | N/A |
Amplify Treatments Testing and Advancements ETF | |||
SPXE | 61.39 | -0.10 | -0.16% |
ProShares S&P 500® ex-Energy | |||
KOKU | 99.41 | -0.56 | -0.56% |
Xtrackers MSCI Kokusai Equity ETF | |||
BBAX | 52.95 | -0.46 | -0.86% |
JPMorgan BetaBuilders Dev APAC ex-JpnETF |